PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling Y Shrestha, EJ Schafer, JS Boehm, SR Thomas, F He, J Du, S Wang, ... Oncogene 31 (29), 3397-3408, 2012 | 175 | 2012 |
Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers HW Cheung, J Du, JS Boehm, F He, BA Weir, X Wang, M Butaney, ... Cancer discovery 1 (7), 608-625, 2011 | 148 | 2011 |
Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer CI Lin, EE Whang, DB Donner, J Du, J Lorch, F He, X Jiang, BD Price, ... Molecular Cancer Research 8 (9), 1217-1226, 2010 | 128 | 2010 |
Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis F He, AE Chiou, HC Loh, M Lynch, BR Seo, YH Song, MJ Lee, R Hoerth, ... Proceedings of the National Academy of Sciences 114 (40), 10542-10547, 2017 | 67 | 2017 |
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer CI Lin, J Du, WT Shen, EE Whang, DB Donner, N Griff, F He, FD Moore Jr, ... The Journal of Clinical Endocrinology & Metabolism 96 (3), E554-E565, 2011 | 50 | 2011 |
Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas JAMR Kunitake, S Choi, KX Nguyen, MM Lee, F He, D Sudilovsky, ... Journal of structural biology 202 (1), 25-34, 2018 | 49 | 2018 |
Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS) F He, NL Springer, MA Whitman, SP Pathi, Y Lee, S Mohanan, S Marcott, ... Biomaterials 224, 119489, 2019 | 25 | 2019 |
ADVANCED BREAST CANCER ALTERS MINERAL PROPERTIES OF THE BONE METASTATIC SITE F He 2018 AAAS Annual Meeting, 2018 | | 2018 |
Mineralized 3D Culture Systems for Studying Bone Metastatic Breast Cancer F He, S Choi, LA Estroff, C Fischbach Engineering 3D Tissue Test Systems, 169-192, 2017 | | 2017 |